NCT07267468 Effectiveness of an mHealth Intervention, Based on Rehabilitation and a Personalised Nutrition Plan, in the Recovery and Improvement of Dysphagia in Patients Diagnosed With Stroke
| NCT ID | NCT07267468 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Cadiz |
| Condition | Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 74 participants |
| Start Date | 2026-01-30 |
| Primary Completion | 2026-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 74 participants in total. It began in 2026-01-30 with a primary completion date of 2026-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to evaluate the efficacy of an mHealth intervention as a complement to usual clinical practice for the improvement and recovery of dysphagia in patients who have suffered a stroke. The main question it aims to answer is: \- Does the mHealth intervention improve the recovery of dysphagia in post-stroke patients compared to usual care alone? Researchers will compare patients receiving the mHealth intervention plus usual care to see if the combined approach leads to better dysphagia outcomes, reduced negative consequences (e.g., malnutrition, pneumonia), and improved quality of life compared to usual care alone. Participants will be recruited and: * Receive a diagnosis and usual care for post-stroke dysphagia. * Be assigned to either the mHealth intervention group (using a smartphone/tablet app for information and follow-up) or the control group (usual care only). * Be followed up to assess dysphagia recovery, reduction in negative outcomes (like aspiration pneumonia, dehydration), and changes in quality of life.
Eligibility Criteria
Inclusion Criteria: * Subjects aged 18 years or older. * Patients with any degree of impairment in swallowing/oropharyngeal dysphagia to liquids following a stroke (ACV). Exclusion Criteria: * Hospitalized patients presenting any type of visual barrier. * Patients in terminal palliative care. * Patients in the final days of life phase. * Patients with severe cognitive impairment. * Patients with a language barrier regarding the use of the App. Subject Withdrawal Criteria: * Revocation of consent. In this case, the subject will exit the study and will not be replaced by another subject, being considered a "loss". * Lack of adherence to the prescribed training plan exceeding 20% of the scheduled sessions.
Contact & Investigator
Eduardo Sánchez-Sánchez, Ph.D.
PRINCIPAL INVESTIGATOR
University of Cadiz. Andalusian Healthcare Service
Frequently Asked Questions
Who can join the NCT07267468 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07267468 currently recruiting?
Yes, NCT07267468 is actively recruiting participants. Contact the research team at eduardo.sanchez@uca.es for enrollment information.
Where is the NCT07267468 trial being conducted?
This trial is being conducted at Algeciras, Spain.
Who is sponsoring the NCT07267468 clinical trial?
NCT07267468 is sponsored by University of Cadiz. The principal investigator is Eduardo Sánchez-Sánchez, Ph.D. at University of Cadiz. Andalusian Healthcare Service. The trial plans to enroll 74 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.